Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,645 | 9,966 | 8,006 | 6,608 | 8,056 |
| Other current assets | 259 | 357 | 513 | 169 | 336 |
| TOTAL | $9,904 | $10,323 | $8,519 | $6,777 | $8,392 |
| Non-Current Assets | |||||
| PPE Net | 10 | 13 | 19 | 24 | 29 |
| Other Non-Current Assets | 35 | 52 | 68 | 24 | 24 |
| TOTAL | $45 | $65 | $87 | $48 | $53 |
| Total Assets | $9,949 | $10,388 | $8,606 | $6,825 | $8,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 135 | 254 | 260 | 230 | 217 |
| Accrued Expenses | 1,015 | 945 | 1,028 | 563 | 761 |
| TOTAL | $1,150 | $1,199 | $1,288 | $793 | $978 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $4 |
| Total Liabilities | $1,150 | $1,199 | $1,288 | $793 | $982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133 | 121 | 92 | 85 | 64 |
| Common Shares | 2 | 1 | 1 | 1 | 14 |
| Retained earnings | -143,190 | -142,034 | -140,598 | -138,934 | -137,445 |
| TOTAL | $8,799 | $9,189 | $7,318 | $6,032 | $7,463 |
| Total Liabilities And Equity | $9,949 | $10,388 | $8,606 | $6,825 | $8,445 |